These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7654898)

  • 21. [Influence of pravastatin therapy on expression of P-selectin].
    Yin S; Ma L; Xu L
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):461-3. PubMed ID: 11189483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
    Napoli C; Lepore S; Ambrosio G; Chiariello M
    Cardiologia; 1992 Nov; 37(11):761-8. PubMed ID: 1298545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia.
    Lee IT; Lee WJ; Ou HC; Huang CN; Sheu WH
    Metabolism; 2009 Mar; 58(3):416-20. PubMed ID: 19217460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
    Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect.
    Dangas G; Smith DA; Unger AH; Shao JH; Meraj P; Fier C; Cohen AM; Fallon JT; Badimon JJ; Ambrose JA
    Thromb Haemost; 2000 May; 83(5):688-92. PubMed ID: 10823263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pravastatin-associated myopathy. Report of a case.
    Scalvini T; Marocolo D; Cerudelli B; Sleiman I; Balestrieri GP; Giustina G
    Recenti Prog Med; 1995 May; 86(5):198-200. PubMed ID: 7604176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled trial of pravastatin vs probucol in the treatment of primary hypercholesterolemia.
    Gómez-Pérez FJ; Bustamante F; Vergara A; Villaseñor J; Wong B; Rull JA
    Rev Invest Clin; 1992; 44(1):53-61. PubMed ID: 1523350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
    Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
    AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pravastatin treatment on vitamin D metabolites.
    Montagnani M; Loré F; Di Cairano G; Gonnelli S; Ciuoli C; Montagnani A; Gennari C
    Clin Ther; 1994; 16(5):824-9. PubMed ID: 7859242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group.
    Rubenfire M; Maciejko JJ; Blevins RD; Orringer C; Kobylak L; Rosman H
    Arch Intern Med; 1991 Nov; 151(11):2234-40. PubMed ID: 1953228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
    Pan HY; DeVault AR; Brescia D; Willard DA
    Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.
    Shimizu M; Koizumi J; Miyamoto S; Origasa H; Mabuchi H;
    Int J Cardiol; 2005 Mar; 99(3):395-401. PubMed ID: 15771919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of pravastatin and diet in the treatment of hypercholesterolemia].
    Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Mangiacotti L
    Clin Ter; 1995 Oct; 146(10):587-93. PubMed ID: 8585875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pravastatin in the treatment of hypercholesterolemia].
    Gómez Gerique JA
    An Med Interna; 1994 Nov; 11(11):521-2. PubMed ID: 7654897
    [No Abstract]   [Full Text] [Related]  

  • 38. The MEGA study.
    Nango E; Saio T; Yuasa H
    Lancet; 2006 Dec; 368(9552):2051; author reply 2052. PubMed ID: 17161723
    [No Abstract]   [Full Text] [Related]  

  • 39. Beneficial effect of cholesterol-lowering therapy on endothelium-dependent coronary vasodilation in patients with hypercholesterolemia.
    Egashira K; Takeshita A
    Ann N Y Acad Sci; 1995 Jan; 748():622-5. PubMed ID: 7695217
    [No Abstract]   [Full Text] [Related]  

  • 40. The rapid reduction in cardiac events with lipid-lowering therapy: mechanisms and implications.
    Pearson TA; Marx HJ
    Am J Cardiol; 1993 Nov; 72(14):1072-3. PubMed ID: 8213589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.